|
Report Date : |
18.07.2012 |
IDENTIFICATION DETAILS
|
Name : |
SELMORE PHARMACEUTICALS (PVT) LIMITED |
|
|
|
|
Registered Office : |
500, Shadman-1, |
|
|
|
|
Country : |
|
|
|
|
|
Year of Establishment : |
1998 |
|
|
|
|
Com. Reg. No.: |
0039705 |
|
|
|
|
Legal Form : |
Private Limited Company |
|
|
|
|
Line of Business : |
Manufacture &
Marketing of Veterinary Pharmaceuticals and Medicines |
|
|
|
|
No. of Employees : |
102 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
Payment Behaviour : |
No Complaints |
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31st, 2012
|
Country Name |
Previous Rating (31.12.2011) |
Current Rating (31.03.2012) |
|
Pakistan |
B2 |
B2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
SELMORE PHARMACEUTICALS (PVT) LIMITED
|
Registered
Address |
|
500, Shadman-1, Lahore, Pakistan |
|
Tel # |
92 (42) 37591921, 37577361 |
|
Fax # |
92 (42) 37591043 |
|
Email |
|
a. |
Nature of Business |
Manufacture
& Marketing of Veterinary Pharmaceuticals and Medicines |
|
b. |
Year Established |
1998 |
|
c. |
Registration # |
0039705 |
|
Address |
SPL House, 82, R-1, Muhammad Ali Johar
Town, Lahore, Pakistan |
|
Tel # |
92 (42) 35291774,
35291775 |
|
Fax # |
92
(42) 35291776 |
|
Address |
36-KM, Multan Road, Lahore, Pakistan |
|
Tel # |
92 (42) 35380381, 35380382, 35380383 |
|
Fax # |
92 (42) 35380383 |
|
Qavi & Co. (Chartered Accountants) Suite No. 10, 3rd Floor, 3-Civic
Centre, New Garden Town, Lahore, Pakistan |
|
Subject Company was established as a Private Limited Company in 1998 |
|
Authorized Capital |
Rs. 5,000,000/-
divided into 50,000 shares of Rs. 100/- each |
|
Issued & Paid up Capital |
Rs. 5,000,000/-
divided into 50,000 shares of Rs. 100/- each |
|
Names |
Nationality |
Address |
Occupation |
Designation |
|
Mr. Akbar Ali Bhatti Mrs. Shazia Akbar |
Pakistani Pakistani |
SPL House, 82, R-1, Muhammad Ali Johar Town, Lahore SPL House, 82, R-1, Muhammad Ali Johar Town, Lahore |
Business Business |
Chief Executive Director |
|
Names |
No. of Shares |
|
Mr. Akbar Ali Bhatti Mrs. Shazia Akbar |
30,000 20,000 |
A. Subsidiary
None
B. Associated
Companies
- Do -
|
Manufacture & Marketing of Veterinary
Pharmaceuticals and Medicines |
102
|
The capacity and production of the Company’s
plant is indeterminable as it is multi-product and involves varying
processes of manufacture. |
|
Year |
In Pak Rupees |
|
2010 |
130,000,000/- (Estimated) |
|
(1) HEBEI HUARI PHARMACEUTICAL CO. LTD, CHINA. (2) SHANDONG PHARMACEUTICAL
GLASS CO LTD, CHINA. (3) JIANGYIN
SUNWAY IMPORT & EXPORT CO LTD, CHINA. |
|
Mainly in Lahore, Karachi, Rawalpindi,
Faisalabad & Multan |
|
(1) Allied Bank Limited, Pakistan. (2) Habib Bank Limited, Pakistan. (3) KASB Bank Limited, Pakistan. (4) Bank Alfalah Limited, Pakistan. |
·
Lahore Chamber of Commerce & Industry.(LCCI)
|
Currency |
Unit |
Pakistani Rupee |
|
US Dollar |
1 |
Rs. 94.80 |
|
UK Pound |
1 |
Rs. 146.70 |
|
Euro |
1 |
Rs. 116.10 |
Subject Company was established in 1998 and is engaged in manufacture
& marketing of Veterinary Pharmaceuticals & Medicines. Trade relations are
reported as fair. Company can be considered for normal business dealings at
usual trade terms & conditions.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.55.15 |
|
|
1 |
Rs.86.30 |
|
Euro |
1 |
Rs.67.73 |
INFORMATION DETAILS
|
Report Prepared
by : |
PRL |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this report.
The assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any risk
and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its
officials.